Douglas H. Thamm

Dr. Thamm is an Associate Professor and Barbara Cox Anthony Chair in Oncology and the Director of Clinical Research at the Colorado State University Animal Cancer Center. He is also a member of the Developmental Therapeutics Section of the University of Colorado Comprehensive Cancer Center and the Cell and Molecular Biology Graduate Program at Colorado State University. Dr. Thamm received his Bachelor’s and V.M.D. degrees from the University of Pennsylvania. He completed a Residency in Medical Oncology at the University of Wisconsin, and was a researcher there for 5 additional years before joining the faculty at CSU in 2004. He is the author of over 80 peer-reviewed publications in veterinary and basic cancer research, has been Oncology Section Editor for the most recent 2 editions of Kirk’s Veterinary Therapy and is Co-Editor-In-Chief of the journal Veterinary and Comparative Oncology. His clinical and research interests include novel targeted therapies for animal and human cancer and ways to integrate these therapies with existing treatment. He has conducted over 24 animal cancer trials and was one of the lead veterinary investigators on TANOVEA®-CA1 (rabacfosadine). Dr. Thamm is an internationally recognized veterinary cancer opinion leader.